| Cancer | ID | Symbol | Immune Pathway | P value | FDR value | ES value | Score | number |
|---|---|---|---|---|---|---|---|---|
| SARC | ENSG00000127481 | UBR4 | TCR signaling Pathway | 1.988e-03 | 1.717e-02 | 0.508 | 0.996 | 42 |
| SARC | ENSG00000168883 | USP39 | Antigen Processing and Presentation | 1.672e-03 | 9.637e-03 | 0.5513 | 0.9967 | 42 |
| SARC | ENSG00000168883 | USP39 | Natural Killer Cell Cytotoxicity | 1.672e-03 | 9.637e-03 | 0.5321 | 0.9967 | 48 |
| SARC | ENSG00000168883 | USP39 | TCR signaling Pathway | 1.701e-03 | 9.637e-03 | 0.5371 | 0.9966 | 34 |
| SARC | ENSG00000078140 | UBE2K | Antigen Processing and Presentation | 2.212e-03 | 1.881e-02 | 0.4514 | 0.9956 | 36 |
| SARC | ENSG00000078140 | UBE2K | TCR signaling Pathway | 2.179e-03 | 1.881e-02 | 0.4787 | 0.9956 | 25 |
| SARC | ENSG00000185651 | UBE2L3 | Antigen Processing and Presentation | 2.024e-03 | 1.721e-02 | 0.4989 | 0.996 | 43 |
| SARC | ENSG00000185651 | UBE2L3 | TGFb Family Member Receptor | 1.923e-03 | 1.721e-02 | -0.7354 | -0.9962 | 5 |
| SARC | ENSG00000276043 | UHRF1 | Antigen Processing and Presentation | 2.146e-03 | 1.824e-02 | 0.3988 | 0.9957 | 39 |
| SARC | ENSG00000276043 | UHRF1 | TCR signaling Pathway | 2.141e-03 | 1.824e-02 | 0.4599 | 0.9957 | 29 |
| SARC | ENSG00000147854 | UHRF2 | TCR signaling Pathway | 2.469e-03 | 4.198e-02 | 0.5229 | 0.9951 | 40 |
| SARC | ENSG00000053501 | USE1 | TCR signaling Pathway | 2.304e-03 | 3.917e-02 | -0.4652 | -0.9954 | 37 |
| SARC | ENSG00000132478 | UNK | Antigen Processing and Presentation | 2.299e-03 | 3.908e-02 | -0.6457 | -0.9954 | 44 |